BIOGEN INC. — Director's Dealing 2015

Mar 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2015-03-27

Reporting Person: Sandrock Alfred (Grp SVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-27	Common Stock	S	430	$430.12	Disposed	8574	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.